LifeVantage (LFVN) Competitors $12.73 -0.52 (-3.92%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$12.71 -0.02 (-0.16%) As of 05/21/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock LFVN vs. BCYC, ANAB, COGT, VECT, SION, KROS, IMTX, TYRA, VALN, and MRVIShould you be buying LifeVantage stock or one of its competitors? The main competitors of LifeVantage include Bicycle Therapeutics (BCYC), AnaptysBio (ANAB), Cogent Biosciences (COGT), VectivBio (VECT), Sionna Therapeutics (SION), Keros Therapeutics (KROS), Immatics (IMTX), Tyra Biosciences (TYRA), Valneva (VALN), and Maravai LifeSciences (MRVI). These companies are all part of the "pharmaceutical products" industry. LifeVantage vs. Bicycle Therapeutics AnaptysBio Cogent Biosciences VectivBio Sionna Therapeutics Keros Therapeutics Immatics Tyra Biosciences Valneva Maravai LifeSciences LifeVantage (NASDAQ:LFVN) and Bicycle Therapeutics (NASDAQ:BCYC) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their community ranking, profitability, media sentiment, valuation, dividends, institutional ownership, earnings, risk and analyst recommendations. Which has stronger valuation and earnings, LFVN or BCYC? LifeVantage has higher revenue and earnings than Bicycle Therapeutics. Bicycle Therapeutics is trading at a lower price-to-earnings ratio than LifeVantage, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLifeVantage$222.35M0.72$2.94M$0.6918.45Bicycle Therapeutics$25.72M21.67-$180.66M-$3.14-2.56 Does the MarketBeat Community prefer LFVN or BCYC? LifeVantage received 77 more outperform votes than Bicycle Therapeutics when rated by MarketBeat users. Likewise, 77.97% of users gave LifeVantage an outperform vote while only 70.53% of users gave Bicycle Therapeutics an outperform vote. CompanyUnderperformOutperformLifeVantageOutperform Votes22377.97% Underperform Votes6322.03% Bicycle TherapeuticsOutperform Votes14670.53% Underperform Votes6129.47% Is LFVN or BCYC more profitable? LifeVantage has a net margin of 3.46% compared to Bicycle Therapeutics' net margin of -450.64%. LifeVantage's return on equity of 34.29% beat Bicycle Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets LifeVantage3.46% 34.29% 15.04% Bicycle Therapeutics -450.64%-27.35%-20.81% Does the media refer more to LFVN or BCYC? In the previous week, Bicycle Therapeutics had 5 more articles in the media than LifeVantage. MarketBeat recorded 5 mentions for Bicycle Therapeutics and 0 mentions for LifeVantage. LifeVantage's average media sentiment score of 1.76 beat Bicycle Therapeutics' score of 0.82 indicating that LifeVantage is being referred to more favorably in the media. Company Overall Sentiment LifeVantage Very Positive Bicycle Therapeutics Positive Do analysts rate LFVN or BCYC? LifeVantage presently has a consensus target price of $30.50, suggesting a potential upside of 139.59%. Bicycle Therapeutics has a consensus target price of $25.00, suggesting a potential upside of 210.56%. Given Bicycle Therapeutics' higher probable upside, analysts plainly believe Bicycle Therapeutics is more favorable than LifeVantage.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LifeVantage 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Bicycle Therapeutics 0 Sell rating(s) 3 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.70 Which has more volatility and risk, LFVN or BCYC? LifeVantage has a beta of 0.41, suggesting that its share price is 59% less volatile than the S&P 500. Comparatively, Bicycle Therapeutics has a beta of 1.6, suggesting that its share price is 60% more volatile than the S&P 500. Do insiders & institutionals have more ownership in LFVN or BCYC? 35.3% of LifeVantage shares are owned by institutional investors. Comparatively, 86.2% of Bicycle Therapeutics shares are owned by institutional investors. 20.7% of LifeVantage shares are owned by company insiders. Comparatively, 22.9% of Bicycle Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. SummaryLifeVantage beats Bicycle Therapeutics on 11 of the 18 factors compared between the two stocks. Get LifeVantage News Delivered to You Automatically Sign up to receive the latest news and ratings for LFVN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LFVN vs. The Competition Export to ExcelMetricLifeVantagePharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$160.25M$6.53B$5.38B$8.39BDividend Yield1.27%2.65%5.21%4.10%P/E Ratio22.738.9226.8019.71Price / Sales0.72252.24389.55117.28Price / Cash19.0365.8538.2534.62Price / Book5.356.466.804.50Net Income$2.94M$143.98M$3.23B$248.18M7 Day Performance0.95%2.03%1.53%0.23%1 Month Performance2.66%4.11%10.05%12.39%1 Year Performance70.41%-2.87%16.75%7.07% LifeVantage Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LFVNLifeVantage4.0033 of 5 stars$12.73-3.9%$30.50+139.6%+77.8%$160.25M$222.35M22.73260Gap DownBCYCBicycle Therapeutics3.7852 of 5 stars$8.60+3.1%$25.00+190.7%-62.7%$595.14M$25.72M-2.61240Gap UpANABAnaptysBio3.3078 of 5 stars$20.03+2.2%$35.88+79.1%-13.1%$588.48M$111.87M-3.29100Positive NewsGap DownCOGTCogent Biosciences2.3648 of 5 stars$5.13+6.7%$14.29+178.5%-37.1%$584.08MN/A-2.0780News CoveragePositive NewsAnalyst ForecastGap DownVECTVectivBioN/A$16.85flatN/AN/A$573.24M$27.34M0.0030High Trading VolumeSIONSionna TherapeuticsN/A$12.90+4.7%$38.50+198.4%N/A$569.20MN/A0.0035KROSKeros Therapeutics3.2298 of 5 stars$13.74+0.7%$37.00+169.3%-72.2%$558.05M$214.71M-2.64100IMTXImmatics2.8249 of 5 stars$4.56+7.5%$16.67+265.5%-51.8%$554.27M$155.84M-6.91260News CoveragePositive NewsTYRATyra Biosciences1.6717 of 5 stars$10.26+1.7%$30.83+200.5%-47.1%$544.70MN/A-6.3720News CoveragePositive NewsAnalyst ForecastAnalyst RevisionVALNValneva2.0997 of 5 stars$6.45-0.3%$15.50+140.3%-22.2%$539.45M$169.58M-49.62700MRVIMaravai LifeSciences4.0811 of 5 stars$2.12+7.1%$6.34+199.2%-79.5%$539.19M$259.19M-1.29610 Related Companies and Tools Related Companies Bicycle Therapeutics Competitors AnaptysBio Competitors Cogent Biosciences Competitors VectivBio Competitors Sionna Therapeutics Competitors Keros Therapeutics Competitors Immatics Competitors Tyra Biosciences Competitors Valneva Competitors Maravai LifeSciences Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LFVN) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredExclusive Offer: Target 100% Returns NowBrace yourself–this may come as a shock. It turns out that you may not have to wait decades to turn a small...ProsperityPub | SponsoredPrepare now for May 31 eventPrepare now for May 31 event Circle May 31 on your calendar This man grew up in a trailer in New Mexico. To...Stansberry Research | SponsoredMemorial Day: 59% dividend from Bitcoin (No Crypto Needed)140% Dividends from stocks like Tesla? Discover How for Just $9! For Memorial Day, get the full details of ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LifeVantage Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share LifeVantage With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LFVN Stock Free LFVN Stock Alerts